BioPharmX Corp (BPMX) has 20 open-market insider trades by 8 insiders since 2015. The most active filer is Stephen Morlock, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vivo Capital Fund VIII, L.P. via Albert Cha | 10% Owner | — | 1 | $2.0M | 2017-04-28 |
| Vivo Capital VIII, LLC | 10% Owner | — | 3 | $1.5M | 2019-06-25 |
| Franklin Resources Inc. | 10% Owner | — | 3 | $1.4M | 2017-08-01 |
| Stephen Morlock | Dir | — | 8 | $534K | 2018-10-22 |
| Anja B. Krammer | Dir | — | 2 | $108K | 2019-01-23 |
| David S. Tierney | CEO | — | 1 | $20K | 2018-09-19 |
| TardiMed Sciences LLC via Michael Derby | 10% | — | 1 | $550 | 2020-02-10 |
| Timber Pharmaceuticals LLC | 10% | — | 1 | $550 | 2020-02-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| TardiMed Sciences LLC | 10% | Sell | $550 | 2020-02-10 |
| Vivo Capital VIII, LLC | 10% Owner | Sell | $669K | 2019-06-25 |
| Anja B. Krammer | Director | Sell | $13K | 2019-01-23 |
| Stephen Morlock | Director | Sell | $290K | 2018-10-18 |
| Anja B. Krammer | Director | Sell | $95K | 2018-10-10 |
| David S. Tierney | CEO | Buy | $20K | 2018-09-19 |
Companies that share insiders with BPMX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Vivo Capital VIII, LLC | 10% Owner | Sell | $720K | 2018-03-07 |
| Stephen Morlock | Director | Buy | $50K | 2017-11-24 |
| Vivo Capital VIII, LLC | 10% Owner | Sell | $119K | 2017-11-09 |
| Franklin Resources Inc. | 10% Owner | Buy | $85K | 2017-08-01 |
| Vivo Capital Fund VIII, L.P. | 10% Owner | Buy | $2.0M | 2017-04-28 |
| Stephen Morlock | Director | Buy | $150K | 2016-11-28 |
| Franklin Resources Inc. | 10% Owner | Buy | $630K | 2016-08-15 |
| Franklin Resources Inc. | 10% Owner | Buy | $648K | 2016-03-29 |
| Stephen Morlock | Director | Buy | $18K | 2016-01-13 |